Key immunotherapy breakthroughs include checkpoint inhibitors (like Merck's Keytruda, often combined with vaccines), adoptive cell therapies such as CAR T-cell therapy, and oncolytic viruses, which directly target and destroy cancer cells while stimulating an immune response.